ID   KAPCB_HUMAN             Reviewed;         351 AA.
AC   P22694; B1APG4; B4DKB0; B4E2Q1; Q14VH1; Q59GC0; Q5BNE9; Q5BNF0;
AC   Q5BNF1; Q5BNF2; Q5BNF3; Q5CZ92; Q5T1K3; Q7Z3M1; Q8IYR5; Q8IZQ0;
AC   Q96B09;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   15-MAR-2017, entry version 186.
DE   RecName: Full=cAMP-dependent protein kinase catalytic subunit beta;
DE            Short=PKA C-beta;
DE            EC=2.7.11.11;
GN   Name=PRKACB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=2342480; DOI=10.1210/mend-4-3-465;
RA   Beebe S.J., Oyen O., Sandberg M., Froysa A., Hansson V., Jahnsen T.;
RT   "Molecular cloning of a tissue-specific protein kinase (C gamma) from
RT   human testis -- representing a third isoform for the catalytic subunit
RT   of cAMP-dependent protein kinase.";
RL   Mol. Endocrinol. 4:465-475(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 7).
RC   TISSUE=Retina, and Salivary gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3; 9 AND 10).
RC   TISSUE=Brain, Thalamus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 8).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-30 (ISOFORMS 2; 5 AND 6), NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 1-16 (ISOFORM 3), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1-13 (ISOFORM 4), AND TISSUE SPECIFICITY.
RX   PubMed=11589697; DOI=10.1046/j.0014-2956.2001.02429.x;
RA   Orstavik S., Reinton N., Frengen E., Langeland B.T., Jahnsen T.,
RA   Skalhegg B.S.;
RT   "Identification of novel splice variants of the human catalytic
RT   subunit Cbeta of cAMP-dependent protein kinase.";
RL   Eur. J. Biochem. 268:5066-5073(2001).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-15 (ISOFORM 1), AND FUNCTION.
RX   PubMed=12420224; DOI=10.1038/sj.onc.1205986;
RA   Wu K.-J., Mattioli M., Morse H.C., Dalla-Favera R.;
RT   "c-MYC activates protein kinase A (PKA) by direct transcriptional
RT   activation of the PKA catalytic subunit beta (PKA-CB) gene.";
RL   Oncogene 21:7872-7882(2002).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PJA2.
RX   PubMed=21423175; DOI=10.1038/ncb2209;
RA   Lignitto L., Carlucci A., Sepe M., Stefan E., Cuomo O., Nistico R.,
RA   Scorziello A., Savoia C., Garbi C., Annunziato L., Feliciello A.;
RT   "Control of PKA stability and signalling by the RING ligase praja2.";
RL   Nat. Cell Biol. 13:412-422(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   MYRISTOYLATION AT GLY-2, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25255805; DOI=10.1038/ncomms5919;
RA   Thinon E., Serwa R.A., Broncel M., Brannigan J.A., Brassat U.,
RA   Wright M.H., Heal W.P., Wilkinson A.J., Mann D.J., Tate E.W.;
RT   "Global profiling of co- and post-translationally N-myristoylated
RT   proteomes in human cells.";
RL   Nat. Commun. 5:4919-4919(2014).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-106.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Mediates cAMP-dependent signaling triggered by receptor
CC       binding to GPCRs. PKA activation regulates diverse cellular
CC       processes such as cell proliferation, the cell cycle,
CC       differentiation and regulation of microtubule dynamics, chromatin
CC       condensation and decondensation, nuclear envelope disassembly and
CC       reassembly, as well as regulation of intracellular transport
CC       mechanisms and ion flux. Regulates the abundance of
CC       compartmentalized pools of its regulatory subunits through
CC       phosphorylation of PJA2 which binds and ubiquitinates these
CC       subunits, leading to their subsequent proteolysis.
CC       {ECO:0000269|PubMed:12420224, ECO:0000269|PubMed:21423175}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Activated by cAMP.
CC   -!- SUBUNIT: A number of inactive tetrameric holoenzymes are produced
CC       by the combination of homo- or heterodimers of the different
CC       regulatory subunits associated with two catalytic subunits. cAMP
CC       causes the dissociation of the inactive holoenzyme into a dimer of
CC       regulatory subunits bound to four cAMP and two free monomeric
CC       catalytic subunits. The cAMP-dependent protein kinase catalytic
CC       subunit binds PJA2 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=3; IntAct=EBI-2679622, EBI-743771;
CC       Q92917:GPKOW; NbExp=4; IntAct=EBI-5258763, EBI-746309;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-2679622, EBI-352572;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21423175}.
CC       Cell membrane {ECO:0000269|PubMed:21423175}. Membrane
CC       {ECO:0000305}; Lipid-anchor {ECO:0000305}. Nucleus {ECO:0000250}.
CC       Note=Translocates into the nucleus (monomeric catalytic subunit).
CC       The inactive holoenzyme is found in the cytoplasm. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC       Name=1; Synonyms=Beta1;
CC         IsoId=P22694-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta2;
CC         IsoId=P22694-2; Sequence=VSP_017364;
CC       Name=3; Synonyms=Beta3;
CC         IsoId=P22694-3; Sequence=VSP_017369, VSP_017370;
CC         Note=Incomplete sequence.;
CC       Name=4; Synonyms=Beta4;
CC         IsoId=P22694-4; Sequence=VSP_017368, VSP_017371;
CC         Note=Incomplete sequence.;
CC       Name=5; Synonyms=Beta4ab;
CC         IsoId=P22694-5; Sequence=VSP_017366;
CC         Note=Incomplete sequence.;
CC       Name=6; Synonyms=Beta4abc;
CC         IsoId=P22694-6; Sequence=VSP_017365;
CC       Name=7;
CC         IsoId=P22694-7; Sequence=VSP_017367;
CC         Note=No experimental confirmation available.;
CC       Name=8;
CC         IsoId=P22694-8; Sequence=VSP_036556, VSP_036557;
CC       Name=9;
CC         IsoId=P22694-9; Sequence=VSP_043372;
CC         Note=No experimental confirmation available.;
CC       Name=10;
CC         IsoId=P22694-10; Sequence=VSP_017366, VSP_046238;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is most abundant in the brain, with
CC       low level expression in kidney. Isoform 2 is predominantly
CC       expressed in thymus, spleen and kidney. Isoform 3 and isoform 4
CC       are only expressed in the brain. {ECO:0000269|PubMed:11589697}.
CC   -!- PTM: Asn-3 is partially deaminated to Asp giving rise to 2 major
CC       isoelectric variants, called CB and CA respectively.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cAMP subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92426.1; Type=Frameshift; Positions=322; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/prkacb/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M34181; AAA60170.1; -; mRNA.
DR   EMBL; BX537705; CAD97818.1; -; mRNA.
DR   EMBL; BX641026; CAE46017.1; -; mRNA.
DR   EMBL; AB209189; BAD92426.1; ALT_SEQ; mRNA.
DR   EMBL; CR936631; CAI56774.1; -; mRNA.
DR   EMBL; AK091420; BAG52356.1; -; mRNA.
DR   EMBL; AK296482; BAG59122.1; -; mRNA.
DR   EMBL; AK304375; BAG65213.1; -; mRNA.
DR   EMBL; DQ667174; ABG25919.1; -; Genomic_DNA.
DR   EMBL; AL359504; CAI14540.1; -; Genomic_DNA.
DR   EMBL; AL450063; CAI14540.1; JOINED; Genomic_DNA.
DR   EMBL; AL359504; CAI14541.1; -; Genomic_DNA.
DR   EMBL; AL450063; CAI14541.1; JOINED; Genomic_DNA.
DR   EMBL; AL450063; CAI16844.1; -; Genomic_DNA.
DR   EMBL; AL359504; CAI16844.1; JOINED; Genomic_DNA.
DR   EMBL; AL450063; CAI16845.1; -; Genomic_DNA.
DR   EMBL; AL359504; CAI16845.1; JOINED; Genomic_DNA.
DR   EMBL; AL450063; CAI16846.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW73248.1; -; Genomic_DNA.
DR   EMBL; BC016285; AAH16285.1; -; mRNA.
DR   EMBL; BC035058; AAH35058.1; -; mRNA.
DR   EMBL; AY927364; AAX19487.1; -; mRNA.
DR   EMBL; AY927365; AAX19488.1; -; mRNA.
DR   EMBL; AY927366; AAX19489.1; -; mRNA.
DR   EMBL; AY927367; AAX19490.1; -; mRNA.
DR   EMBL; AY927368; AAX19491.1; -; mRNA.
DR   EMBL; AF538872; AAN16454.1; -; Genomic_DNA.
DR   CCDS; CCDS55609.1; -. [P22694-9]
DR   CCDS; CCDS55610.1; -. [P22694-7]
DR   CCDS; CCDS55611.1; -. [P22694-10]
DR   CCDS; CCDS691.1; -. [P22694-1]
DR   CCDS; CCDS692.1; -. [P22694-8]
DR   CCDS; CCDS693.1; -. [P22694-2]
DR   CCDS; CCDS72813.1; -. [P22694-3]
DR   CCDS; CCDS72815.1; -. [P22694-6]
DR   PIR; A34724; OKHUCB.
DR   RefSeq; NP_001229786.1; NM_001242857.2. [P22694-9]
DR   RefSeq; NP_001229787.1; NM_001242858.2. [P22694-3]
DR   RefSeq; NP_001229788.1; NM_001242859.2. [P22694-7]
DR   RefSeq; NP_001229789.1; NM_001242860.2. [P22694-6]
DR   RefSeq; NP_001229790.1; NM_001242861.2. [P22694-10]
DR   RefSeq; NP_001229791.1; NM_001242862.2.
DR   RefSeq; NP_001287844.1; NM_001300915.1.
DR   RefSeq; NP_001287845.1; NM_001300916.1.
DR   RefSeq; NP_001287846.1; NM_001300917.1.
DR   RefSeq; NP_002722.1; NM_002731.3. [P22694-1]
DR   RefSeq; NP_891993.1; NM_182948.3. [P22694-2]
DR   RefSeq; NP_997461.1; NM_207578.2. [P22694-8]
DR   RefSeq; XP_005271076.1; XM_005271019.1. [P22694-4]
DR   RefSeq; XP_006710821.1; XM_006710758.1. [P22694-5]
DR   UniGene; Hs.487325; -.
DR   ProteinModelPortal; P22694; -.
DR   SMR; P22694; -.
DR   BioGrid; 111554; 78.
DR   IntAct; P22694; 45.
DR   MINT; MINT-1178341; -.
DR   STRING; 9606.ENSP00000359719; -.
DR   BindingDB; P22694; -.
DR   ChEMBL; CHEMBL2918; -.
DR   DrugBank; DB02482; Phosphonothreonine.
DR   GuidetoPHARMACOLOGY; 1477; -.
DR   iPTMnet; P22694; -.
DR   PhosphoSitePlus; P22694; -.
DR   SwissPalm; P22694; -.
DR   BioMuta; PRKACB; -.
DR   DMDM; 125210; -.
DR   EPD; P22694; -.
DR   MaxQB; P22694; -.
DR   PaxDb; P22694; -.
DR   PeptideAtlas; P22694; -.
DR   PRIDE; P22694; -.
DR   DNASU; 5567; -.
DR   Ensembl; ENST00000370682; ENSP00000359716; ENSG00000142875. [P22694-7]
DR   Ensembl; ENST00000370685; ENSP00000359719; ENSG00000142875. [P22694-2]
DR   Ensembl; ENST00000370688; ENSP00000359722; ENSG00000142875. [P22694-8]
DR   Ensembl; ENST00000370689; ENSP00000359723; ENSG00000142875. [P22694-1]
DR   Ensembl; ENST00000394839; ENSP00000378315; ENSG00000142875. [P22694-10]
DR   Ensembl; ENST00000446538; ENSP00000401252; ENSG00000142875. [P22694-9]
DR   Ensembl; ENST00000610703; ENSP00000481980; ENSG00000142875. [P22694-3]
DR   Ensembl; ENST00000614872; ENSP00000479722; ENSG00000142875. [P22694-6]
DR   GeneID; 5567; -.
DR   KEGG; hsa:5567; -.
DR   UCSC; uc001dji.4; human. [P22694-1]
DR   CTD; 5567; -.
DR   DisGeNET; 5567; -.
DR   GeneCards; PRKACB; -.
DR   HGNC; HGNC:9381; PRKACB.
DR   HPA; CAB010363; -.
DR   HPA; HPA029754; -.
DR   HPA; HPA071185; -.
DR   MIM; 176892; gene.
DR   neXtProt; NX_P22694; -.
DR   OpenTargets; ENSG00000142875; -.
DR   PharmGKB; PA33749; -.
DR   eggNOG; KOG0616; Eukaryota.
DR   eggNOG; ENOG410XPQQ; LUCA.
DR   GeneTree; ENSGT00810000125385; -.
DR   HOGENOM; HOG000233033; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P22694; -.
DR   KO; K04345; -.
DR   OMA; GKEFCEF; -.
DR   OrthoDB; EOG091G10O8; -.
DR   PhylomeDB; P22694; -.
DR   TreeFam; TF313399; -.
DR   BRENDA; 2.7.11.11; 2681.
DR   Reactome; R-HSA-111931; PKA-mediated phosphorylation of CREB.
DR   Reactome; R-HSA-163358; PKA-mediated phosphorylation of key metabolic factors.
DR   Reactome; R-HSA-163560; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   Reactome; R-HSA-163615; PKA activation.
DR   Reactome; R-HSA-164378; PKA activation in glucagon signalling.
DR   Reactome; R-HSA-180024; DARPP-32 events.
DR   Reactome; R-HSA-194223; HDL-mediated lipid transport.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-HSA-392517; Rap1 signalling.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   Reactome; R-HSA-432040; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-442720; CREB phosphorylation through the activation of Adenylate Cyclase.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   Reactome; R-HSA-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   Reactome; R-HSA-8853659; RET signaling.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SABIO-RK; P22694; -.
DR   SignaLink; P22694; -.
DR   SIGNOR; P22694; -.
DR   ChiTaRS; PRKACB; human.
DR   GeneWiki; PRKACB; -.
DR   GenomeRNAi; 5567; -.
DR   PRO; PR:P22694; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000142875; -.
DR   ExpressionAtlas; P22694; baseline and differential.
DR   Genevisible; P22694; HS.
DR   GO; GO:0005952; C:cAMP-dependent protein kinase complex; TAS:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0097546; C:ciliary base; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004691; F:cAMP-dependent protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0016301; F:kinase activity; TAS:Reactome.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB.
DR   GO; GO:0034199; P:activation of protein kinase A activity; TAS:Reactome.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome.
DR   GO; GO:0042157; P:lipoprotein metabolic process; TAS:Reactome.
DR   GO; GO:0051447; P:negative regulation of meiotic cell cycle; IEA:Ensembl.
DR   GO; GO:1901621; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0070613; P:regulation of protein processing; IEA:Ensembl.
DR   GO; GO:0003091; P:renal water homeostasis; TAS:Reactome.
DR   GO; GO:0097338; P:response to clozapine; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; cAMP; Cell membrane;
KW   Complete proteome; Cytoplasm; Kinase; Lipoprotein; Membrane;
KW   Myristate; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:25255805}.
FT   CHAIN         2    351       cAMP-dependent protein kinase catalytic
FT                                subunit beta.
FT                                /FTId=PRO_0000086060.
FT   DOMAIN       44    298       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      299    351       AGC-kinase C-terminal.
FT   NP_BIND      50     58       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    167    167       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      73     73       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       3      3       Deamidated asparagine. {ECO:0000250}.
FT   MOD_RES      69     69       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P68181}.
FT   MOD_RES     322    322       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P68182}.
FT   MOD_RES     339    339       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P68182}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:25255805}.
FT   VAR_SEQ       1     16       MGNAATAKKGSEVESV -> MAAYREPPCNQYTGTTTALQK
FT                                LEGFASRLFHRHSKGTAHDQKTALENDSLHFSEHTALWDRS
FT                                M (in isoform 2).
FT                                {ECO:0000303|PubMed:11589697,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_017364.
FT   VAR_SEQ       1     15       MGNAATAKKGSEVES -> MSARKSSDASACSSSEISDSF
FT                                (in isoform 6).
FT                                {ECO:0000303|PubMed:11589697,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_017365.
FT   VAR_SEQ       1     15       MGNAATAKKGSEVES -> MGLSRKSSDASACSSSEISDSF
FT                                (in isoform 9).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043372.
FT   VAR_SEQ       1     14       MGNAATAKKGSEVE -> MSARKSSDASACSSSEI (in
FT                                isoform 5 and isoform 10).
FT                                {ECO:0000303|PubMed:11589697,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017366.
FT   VAR_SEQ       1     14       MGNAATAKKGSEVE -> MGLSRKSSDASACSSSEI (in
FT                                isoform 7).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_017367.
FT   VAR_SEQ       1     13       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11589697}.
FT                                /FTId=VSP_017368.
FT   VAR_SEQ       1     12       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11589697,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017369.
FT   VAR_SEQ      13     16       VESV -> MGLL (in isoform 3).
FT                                {ECO:0000303|PubMed:11589697,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017370.
FT   VAR_SEQ      14     14       E -> M (in isoform 4).
FT                                {ECO:0000303|PubMed:11589697}.
FT                                /FTId=VSP_017371.
FT   VAR_SEQ      79    111       Missing (in isoform 10).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046238.
FT   VAR_SEQ     256    257       VR -> NF (in isoform 8).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036556.
FT   VAR_SEQ     258    351       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036557.
FT   VARIANT     106    106       R -> Q (in dbSNP:rs36117118).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040594.
FT   CONFLICT     80     80       V -> G (in Ref. 3; CAI56774).
FT                                {ECO:0000305}.
FT   CONFLICT    159    159       H -> N (in Ref. 8; AAH35058).
FT                                {ECO:0000305}.
FT   CONFLICT    163    163       L -> I (in Ref. 8; AAH35058).
FT                                {ECO:0000305}.
FT   CONFLICT    233    233       A -> V (in Ref. 3; CAI56774).
FT                                {ECO:0000305}.
FT   CONFLICT    261    261       H -> N (in Ref. 8; AAH35058).
FT                                {ECO:0000305}.
SQ   SEQUENCE   351 AA;  40623 MW;  5C7443FBBA1C9BEC CRC64;
     MGNAATAKKG SEVESVKEFL AKAKEDFLKK WENPTQNNAG LEDFERKKTL GTGSFGRVML
     VKHKATEQYY AMKILDKQKV VKLKQIEHTL NEKRILQAVN FPFLVRLEYA FKDNSNLYMV
     MEYVPGGEMF SHLRRIGRFS EPHARFYAAQ IVLTFEYLHS LDLIYRDLKP ENLLIDHQGY
     IQVTDFGFAK RVKGRTWTLC GTPEYLAPEI ILSKGYNKAV DWWALGVLIY EMAAGYPPFF
     ADQPIQIYEK IVSGKVRFPS HFSSDLKDLL RNLLQVDLTK RFGNLKNGVS DIKTHKWFAT
     TDWIAIYQRK VEAPFIPKFR GSGDTSNFDD YEEEDIRVSI TEKCAKEFGE F
//
